tradingkey.logo

Bone Biologics Corp

BBLG
View Detailed Chart

2.730USD

0.0000.00%
Close 08/01, 16:00ETQuotes delayed by 15 min
8.93MMarket Cap
LossP/E TTM

Bone Biologics Corp

2.730

0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Today

-2.50%

5 Days

-9.60%

1 Month

-21.78%

6 Months

+114.96%

Year to Date

+190.33%

1 Year

+0.37%

View Detailed Chart

Agency Rating

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(8)
Neutral(2)
Buy(2)
Indicators
Sell(4)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.083
Sell
RSI(14)
41.847
Neutral
STOCH(KDJ)(9,3,3)
21.810
Neutral
ATR(14)
0.158
Low Volatility
CCI(14)
-139.356
Sell
Williams %R
84.158
Oversold
TRIX(12,20)
-1.065
Sell
StochRSI(14)
31.442
Sell
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
2.792
Sell
MA10
2.902
Sell
MA20
2.929
Sell
MA50
3.088
Sell
MA100
1.922
Buy
MA200
1.548
Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Bone Biologics Corporation is a developer of orthobiologic products for spine fusion markets. It is focusing development efforts for its bone graft substitute product on bone regeneration in spinal fusion procedures, while additionally having rights to trauma and osteoporosis applications. It is a medical device company that is focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with demineralized bone matrix (DBM), is an osteopromotive recombinant protein that provides target specific control over bone regeneration. Its platform technology is its NELL-1, a proprietary skeletal specific growth factor which is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.
Ticker SymbolBBLG
CompanyBone Biologics Corp
CEOMr. Jeffrey Frelick
Websitehttps://www.bonebiologics.com/
KeyAI